202 related articles for article (PubMed ID: 20585043)
21. MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathway.
Kumkhaek C; Aerbajinai W; Liu W; Zhu J; Uchida N; Kurlander R; Hsieh MM; Tisdale JF; Rodgers GP
Blood; 2013 Apr; 121(16):3216-27. PubMed ID: 23327923
[TBL] [Abstract][Full Text] [Related]
22. Small-molecule α-lipoic acid targets ELK1 to balance human neutrophil and erythrocyte differentiation.
Zhang Y; Zhou Y; Li X; Pan X; Bai J; Chen Y; Lai Z; Chen Q; Ma F; Dong Y
Stem Cell Res Ther; 2024 Apr; 15(1):100. PubMed ID: 38589882
[TBL] [Abstract][Full Text] [Related]
23. NF-E2 overexpression delays erythroid maturation and increases erythrocyte production.
Mutschler M; Magin AS; Buerge M; Roelz R; Schanne DH; Will B; Pilz IH; Migliaccio AR; Pahl HL
Br J Haematol; 2009 Jul; 146(2):203-17. PubMed ID: 19466964
[TBL] [Abstract][Full Text] [Related]
24. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
25. Cooperative Effect of Erythropoietin and TGF-β Inhibition on Erythroid Development in Human Pluripotent Stem Cells.
Xie Y; Bai H; Liu Y; Hoyle DL; Cheng T; Wang ZZ
J Cell Biochem; 2015 Dec; 116(12):2735-43. PubMed ID: 26012423
[TBL] [Abstract][Full Text] [Related]
26. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.
Jamieson CH; Gotlib J; Durocher JA; Chao MP; Mariappan MR; Lay M; Jones C; Zehnder JL; Lilleberg SL; Weissman IL
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6224-9. PubMed ID: 16603627
[TBL] [Abstract][Full Text] [Related]
27. HGF activates signal transduction from EPO receptor on human cord blood CD34+/CD45+ cells.
Iguchi T; Sogo S; Hisha H; Taketani S; Adachi Y; Miyazaki R; Ogata H; Masuda S; Sasaki R; Ito M; Fukuhara S; Ikehara S
Stem Cells; 1999; 17(2):82-91. PubMed ID: 10195568
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
Josefsen D; Myklebust JH; Lømo J; Sioud M; Blomhoff HK; Smeland EB
Stem Cells; 2000; 18(4):261-72. PubMed ID: 10924092
[TBL] [Abstract][Full Text] [Related]
29. Human hematopoietic progenitors express erythropoietin.
Stopka T; Zivny JH; Stopkova P; Prchal JF; Prchal JT
Blood; 1998 May; 91(10):3766-72. PubMed ID: 9573013
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow.
Myklebust JH; Smeland EB; Josefsen D; Sioud M
Blood; 2000 Jan; 95(2):510-8. PubMed ID: 10627456
[TBL] [Abstract][Full Text] [Related]
31. STAT3 is constitutively active in some patients with Polycythemia rubra vera.
Röder S; Steimle C; Meinhardt G; Pahl HL
Exp Hematol; 2001 Jun; 29(6):694-702. PubMed ID: 11378264
[TBL] [Abstract][Full Text] [Related]
32. Total saponins of Panax ginseng (TSPG) promote erythroid differentiation of human CD34+ cells via EpoR-mediated JAK2/STAT5 signaling pathway.
Chen D; Zuo G; Li C; Hu X; Guan T; Jiang R; Li J; Lin X; Li F; Luo C; Wang H; Lei C; Long X; Wang Y; Wang J
J Ethnopharmacol; 2009 Nov; 126(2):215-20. PubMed ID: 19735711
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of polycythemia vera--new concepts.
Golde DW; Cline MJ
Am J Hematol; 1976; 1(3):351-5. PubMed ID: 793383
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera.
Hricik T; Federici G; Zeuner A; Alimena G; Tafuri A; Tirelli V; Varricchio L; Masiello F; Ciaffoni F; Vaglio S; Petricoin EF; Girelli G; Levine RL; Migliaccio AR
Am J Hematol; 2013 Sep; 88(9):723-9. PubMed ID: 23720412
[TBL] [Abstract][Full Text] [Related]
35. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of polycythaemia vera.
Green AR
Lancet; 1996 Mar; 347(9005):844-5. PubMed ID: 8622384
[No Abstract] [Full Text] [Related]
37. Polycythemia vera: scientific advances and current practice.
Tefferi A; Spivak JL
Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
[TBL] [Abstract][Full Text] [Related]
38. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
Shih LY; Huang JY
Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
[TBL] [Abstract][Full Text] [Related]
39. Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.
Akada H; Yan D; Zou H; Fiering S; Hutchison RE; Mohi MG
Blood; 2010 Apr; 115(17):3589-97. PubMed ID: 20197548
[TBL] [Abstract][Full Text] [Related]
40. L3MBTL1 deficiency directs the differentiation of human embryonic stem cells toward trophectoderm.
Hoya-Arias R; Tomishima M; Perna F; Voza F; Nimer SD
Stem Cells Dev; 2011 Nov; 20(11):1889-900. PubMed ID: 21341991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
